Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury

Autologous Bone Marrow Mononuclear Cell Therapy for Spinal Cord Injury

The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.

Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by standard rehabilitation therapy.

Inclusion Criteria:

• Diagnosed cases of any type of chronic Spinal cord injury
• Age above 6 months

Exclusion Criteria:

• presence of acute infections such as Human immunodeficiency virus/ Hepatitis B Virus/ Hepatitis C Virus
• malignancies
• bleeding tendencies
• pneumonia
• renal failure
• severe liver dysfunction
• severe anemia [Hemoglobin < 8]
• any bone marrow disorder
• other acute medical conditions such as respiratory infection
• pregnancy and lactation